ImmunityBio Stock: All Eyes On Execution Now (NASDAQ:IBRX)

Topline Summary and Update

ImmunityBio (NASDAQ:IBRX) has been a fascinating story to watch, coming about as close to “meme stock” as we have seen in the biotech space due to the convergence of a highly dedicated shareholder base, successful

Read the full article here